PHARMALEX.COM: Keyword Density Checker

Total words: 2818 | 2-word phrases: 750 | 3-word phrases: 805 | 4-word phrases: 840

PAGE INFO

Title	Try to keep the title under 60 characters (64 characters) Specialized services for the pharmaceutical industry - PharmaLex
Description	Try to keep the meta description between 50 - 160 characters (136 characters) Pharma consulting of specialized services for the pharmaceutical, biotech and medical device industries, compliance is our top priority.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (61 characters) Global solutions wherever you are in your product's lifecycle

ONE WORD PHRASES 423 Words

#	Keyword	Frequency	Density
1	and	59	13.95%
2	to	25	5.91%
3	our	16	3.78%
4	are	14	3.31%
5	patient	14	3.31%
6	development	12	2.84%
7	of	12	2.84%
8	the	11	2.60%
9	access	10	2.36%
10	market	10	2.36%

TWO WORD PHRASES 750 Words

#	Keyword	Frequency	Density
1	journal article	7	0.93%
2	white paper	7	0.93%
3	patient safety	6	0.80%
4	strategic and	6	0.80%
5	and scientific	6	0.80%
6	product development	6	0.80%
7	innovations to	6	0.80%
8	to market	6	0.80%
9	optimal patient	6	0.80%
10	business and	6	0.80%
11	we are	6	0.80%
12	patient access	6	0.80%
13	and portfolio	5	0.67%
14	about us	5	0.67%
15	white papers	5	0.67%
16	integrated product	5	0.67%
17	consultancy integrated	5	0.67%
18	quality management	4	0.53%
19	management team	4	0.53%
20	scientific consultancy	4	0.53%

THREE WORD PHRASES 805 Words

#	Keyword	Frequency	Density
1	innovations to market	6	0.75%
2	strategic and scientific	6	0.75%
3	optimal patient access	6	0.75%
4	business and portfolio	5	0.62%
5	integrated product development	5	0.62%
6	and scientific consultancy	4	0.50%
7	quality management and	4	0.50%
8	consultancy integrated product	4	0.50%
9	patient safety pharmacovigilance	3	0.37%
10	statistics and data	3	0.37%
11	affairs and cmc	3	0.37%
12	sustainability management team	3	0.37%
13	scientific consultancy integrated	3	0.37%
14	product development innovations	3	0.37%
15	development innovations to	3	0.37%
16	science market access	3	0.37%
17	to market optimal	3	0.37%
18	patient access business	3	0.37%
19	access business and	3	0.37%
20	pharmacovigilance and improving	3	0.37%
21	management and compliance	3	0.37%
22	new technologies are	3	0.37%
23	market optimal patient	3	0.37%
24	we on the	2	0.25%
25	market access patient	2	0.25%
26	access patient safety	2	0.25%
27	out evidentiary expectations	2	0.25%
28	safety pharmacovigilance regulatory	2	0.25%
29	20 years of	2	0.25%
30	fda sets out	2	0.25%

FOUR WORD PHRASES 840 Words

#	Keyword	Frequency	Density
1	consultancy integrated product development	4	0.48%
2	strategic and scientific consultancy	4	0.48%
3	patient access business and	3	0.36%
4	optimal patient access business	3	0.36%
5	innovations to market optimal	3	0.36%
6	access business and portfolio	3	0.36%
7	development innovations to market	3	0.36%
8	product development innovations to	3	0.36%
9	quality management and compliance	3	0.36%
10	to market optimal patient	3	0.36%
11	market optimal patient access	3	0.36%
12	and scientific consultancy integrated	3	0.36%
13	thought leadership white papers	2	0.24%
14	events company news thought	2	0.24%
15	research and development statistics	2	0.24%
16	and development statistics and	2	0.24%
17	development statistics and data	2	0.24%
18	business and portfolio mergersacquisitions	2	0.24%
19	control strategy css overview	2	0.24%
20	contamination control strategy css	2	0.24%
21	enhancing our industry by	2	0.24%
22	on the right track?	2	0.24%
23	webinars events company news	2	0.24%
24	we on the right	2	0.24%
25	cmc quality management and	2	0.24%
26	company news thought leadership	2	0.24%
27	science market access patient	2	0.24%
28	and cmc quality management	2	0.24%
29	years of biosimilars are	2	0.24%
30	20 years of biosimilars	2	0.24%
31	affairs and cmc quality	2	0.24%
32	news thought leadership white	2	0.24%
33	access patient safety pharmacovigilance	2	0.24%
34	videos journal articles podcasts	2	0.24%
35	blogarticles videos journal articles	2	0.24%
36	infographics blogarticles videos journal	2	0.24%
37	market access patient safety	2	0.24%
38	patient safety pharmacovigilance regulatory	2	0.24%
39	training courses solutions industry	2	0.24%
40	responsibility sustainability management team	2	0.24%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://go.cencora.com/20_Years_Biosimilars	Whois	cencora.com
2	https://go.cencora.com/20_Years_Biosimilars	Whois	cencora.com
3	https://www.bioprocessintl.com/information-technology/centralize-modernize-harmonize-the-acceleration-of-regulatory-digital-trends	Whois	bioprocessintl.com
4	https://www.bioprocessintl.com/information-technology/centralize-modernize-harmonize-the-acceleration-of-regulatory-digital-trends	Whois	bioprocessintl.com
5	https://go.cencora.com/20_Years_Biosimilars	Whois	cencora.com
6	https://us06web.zoom.us/webinar/register/3617151844654/WN_I-PJMq6iRr2nGpJ-ULcr8w	Whois	zoom.us
7	https://www.bioprocessintl.com/information-technology/centralize-modernize-harmonize-the-acceleration-of-regulatory-digital-trends	Whois	bioprocessintl.com
8	https://www.cencora.com/modern-slavery-act-disclosure-statement	Whois	cencora.com
9	https://www.cencora.com/modern-slavery-act-disclosure-statement	Whois	cencora.com